Therapeutic Sequencing in Metastatic Renal Cell Carcinoma
The influx of multiple novel therapeutic options in the mRCC field has brought a challenge for treatment sequencing in this disease. In the past few years, cabozantinib, nivolumab and the combination of lenvatinib and everolimus have been approved in the second-line setting. As there is no direct co...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publishing
2017-07-01
|
| Col·lecció: | Kidney Cancer |
| Accés en línia: | https://doi.org/10.3233/KCA-170006 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|